Alternative bisphosphonate targets and mechanisms of action
- PMID: 15694409
- DOI: 10.1016/j.bbrc.2004.11.075
Alternative bisphosphonate targets and mechanisms of action
Abstract
As the number of bisphosphonates continues to increase, they have found widespread use in an increasing number of clinical conditions. Ongoing examination of their targets and mechanisms of action has revealed that this surprisingly diverse class of drugs has effects beyond those first described for osteoclasts. These additional targets include osteoblasts, osteocytes, angiogenesis, and gammadelta T lymphocytes of the human immune system. The immune system effects are specifically targeted to gammadelta T cells and are reminiscent of the effects seen after ingestion of tea beverage. BP effects on such alternate targets may explain not only their antiresorptive effect, but also their effect on bone quality, tumors, and microbes.
Comment in
-
Bisphosphonates may potentiate radiation effects: a new approach in cancer treatment?Biochem Biophys Res Commun. 2005 Oct 21;336(2):373-4. doi: 10.1016/j.bbrc.2005.07.120. Biochem Biophys Res Commun. 2005. PMID: 16098478 No abstract available.
Similar articles
-
Bisphosphonates: an update on mechanisms of action and how these relate to clinical efficacy.Ann N Y Acad Sci. 2007 Nov;1117:209-57. doi: 10.1196/annals.1402.089. Ann N Y Acad Sci. 2007. PMID: 18056045 Review.
-
In vitro comparison of clodronate, pamidronate and zoledronic acid effects on rat osteoclasts and human stem cell-derived osteoblasts.Basic Clin Pharmacol Toxicol. 2005 Dec;97(6):382-91. doi: 10.1111/j.1742-7843.2005.pto_176.x. Basic Clin Pharmacol Toxicol. 2005. PMID: 16364054
-
In vitro and in vivo antiresorptive effects of bisphosphonates in metastatic bone disease.In Vivo. 2005 Jan-Feb;19(1):311-8. In Vivo. 2005. PMID: 15796191 Review.
-
[Bisphosphonates and bone metastases of solid tumors: therapeutic interest despite its anti-resorptive properties].Prog Urol. 2003 Apr;13(2 Suppl 1):28-35. Prog Urol. 2003. PMID: 12815807 Review. French. No abstract available.
-
[Long-term bisphosphonate administration and its effect on bone metabolism].Clin Calcium. 2005 Apr;15(4):643-7. Clin Calcium. 2005. PMID: 15802778 Review. Japanese.
Cited by
-
A novel soft-tissue in vitro model for bisphosphonate-associated osteonecrosis.Fibrogenesis Tissue Repair. 2010 Apr 1;3:6. doi: 10.1186/1755-1536-3-6. Fibrogenesis Tissue Repair. 2010. PMID: 20359336 Free PMC article.
-
Local treatment of a bone graft by soaking in zoledronic acid inhibits bone resorption and bone formation. A bone chamber study in rats.BMC Musculoskelet Disord. 2012 Dec 5;13:240. doi: 10.1186/1471-2474-13-240. BMC Musculoskelet Disord. 2012. PMID: 23217097 Free PMC article.
-
Bisphophonates in CKD patients with low bone mineral density.ScientificWorldJournal. 2013 Dec 31;2013:837573. doi: 10.1155/2013/837573. eCollection 2013. ScientificWorldJournal. 2013. PMID: 24501586 Free PMC article. Review.
-
Effects of clodronate combined with hydroxyapatite on multi-directional differentiation of mesenchymal stromal cells.Arch Med Sci. 2010 Oct;6(5):670-7. doi: 10.5114/aoms.2010.17079. Epub 2010 Oct 26. Arch Med Sci. 2010. PMID: 22419923 Free PMC article.
-
The Therapeutic Potential of Secreted Factors from Dental Pulp Stem Cells for Various Diseases.Biomedicines. 2022 May 2;10(5):1049. doi: 10.3390/biomedicines10051049. Biomedicines. 2022. PMID: 35625786 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials